ISSCR News
Cédric Blanpain Receives the 2023 ISSCR Momentum Award
The International Society for Stem Cell Research (ISSCR) will present this year’s ISSCR Momentum Award to Cédric Blanpain, M.D., Ph.D., professor and director of the laboratory of stem cells and cancer at the Université Libre de Bruxelles, Belgium. The prize recognizes the exceptional achievements of an investigator whose innovative research has established a major area of stem cell-related research with a strong trajectory for future success.
ISSCR Offers Recommendations on Risk Mitigation in Advancing Stem Cell Therapies
On 13 December 2022, ISSCR hosted its annual Liaison Meeting with the U.S. Food and Drug Administration. FDA professionals gathered virtually with ISSCR leaders to discuss advances in the development of stem cell therapies.
Voting Opens for 2023 ISSCR Board of Directors and Officers
Help to shape the future of your society by voting in the 2023 ISSCR Board of Directors election. Each year, together, we select global leaders to be our representatives — as champions, thought leaders, and stewards of the field. Your vote matters.
Call for Abstracts and Registration Are Open for ISSCR 2023 Annual Meeting 14-17 June 2023
Abstracts and registration are open for the ISSCR 2023 Annual Meeting, the most comprehensive gathering of scientists in stem cell research and regenerative medicine in the world. Taking place 14-17 June 2023 in Boston, USA, a global powerhouse for biomedical innovation, this hallmark event, co-sponsored by BlueRock Therapeutics, offers attendees opportunities for scientific exchange and relationship building for an unparalleled experience that showcases the year’s most compelling stem cell research and clinical breakthroughs.
Stem cells provide a model to understand sensorineural hearing loss
Disabling hearing loss affects one in every ten people and up to 25% of people over 60, according to the World Health Organization. Sensorineural hearing loss, the most frequent form of hearing loss, is caused by damage to specialized cells in the cochlea called hair cells (HCs) and spiral ganglion neurons (SGNs), respectively, both of which are essential for hearing. According to the authors of a recent paper published in Stem Cell Reports, researchers have generated “cochlear organoids with functional synapses for the first time, which provides a platform for deciphering the mechanisms of sensorineural hearing loss,” opening up avenues for investigating new therapeutic approaches.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .